is a type of immunotherapy for large B-cell lymphoma (LBCL) cancer that uses your own modified T cells to locate and destroy lymphoma cells.
CAR (chimeric antigen receptor) T-cell therapy
CAR T-cell therapy is typically used for aggressive LBCL that has returned or resisted earlier treatments.
Chemotherapy
Chemoimmunotherapy
Radiation
Your T cells are collected and sent to a lab, where they are “retrained” to identify and kill cancer cells.
After a round of chemotherapy, your T cells are returned to your body as powerful, cancer-fighting cells.
The entire process — determining your eligibility, collecting and infusing T cells, monitoring closely afterward — takes about three months.
MONTHS
For many people, this treatment can lead to long-term remission, with 45% to 50% achieving a lasting, positive response.
45-50%
